PRODH and atrial fibrillation: PRODH siRNA treatment was used to determine whether PRODH is the direct target of AFs, and we found that the expression of P5CS, P5CR, and proapoptotic factors was no different in AF-treated and siRNA-treated cells, and in cells that were treated with PRODH siRNA alone.